A risk-based identification of essential medicines for local manufacturing in low-and middle-income countries

Overview

A number of papers deal with a variety of aspects of the manufacture of medicines in low- and middle-income countries (LMICs) – including disease to be treated, capacity building, access to medicines, cost, skills, training, etc.; however, the technical level of what is to be produced in conjunction with the risk associated with the product itself is often not adequately addressed. Therefore a paper was prepared to fill this gap.